Skip to content
  • Thu. Nov 5th, 2026
Health Report World

Health Report World

Your Global Resource for Health Insights

  • Home
  • About Us
  • Advertise with Us
  • Contact Us
  • Disclaimer
  • Editorial Policy
  • Fact-Checking & Corrections Policy
  • Sponsored Content Policy
  • Terms & Conditions
  • Write for Us
Top Tags
  • listening
  • healthcare
  • pharmaceutical approval
  • drug approval
  • pharmaceutical news
  • drug development
  • language
pharma

UK MHRA Approval: Is It the Best Choice for Mesalazine?

November 5, 2026 Rose Parker
pharmaceutical news

FDA Approval for Amifampridine: Is it the Best Treatment?

November 2, 2026 Rose Parker
pharmaceuticals

FDA Approval Ketamine Drug: A Proven Breakthrough

October 30, 2026 Rose Parker
pharma

Drug-price controls: The Right Approach for Patient Lives

October 27, 2026 Rose Parker
pharma

Pfizer brand acquisition: The Smart Move for Evonile Pharma

October 23, 2026 Rose Parker
pharma

UK MHRA Approval: Is It the Best Choice for Mesalazine?

UK MHRA approval is crucial for Mesalazine suppositories. Discover what this means for patients and the pharma industry.

November 5, 2026 Rose Parker
pharmaceutical news

FDA Approval for Amifampridine: Is it the Best Treatment?

FDA approval for Amifampridine marks a significant milestone in treatment options for patients.

November 2, 2026 Rose Parker
pharma

Colchicine 0.5 mg tablets: Safe and Proven Treatment Option

Colchicine 0.5 mg tablets are now approved by DCGI, offering a safe treatment option for patients.

September 29, 2026 Rose Parker
finance

Viatris Stock News: The Clear Update You Need

Viatris stock news provides the latest updates on VTRS performance, trends, and insights.

September 27, 2026 Rose Parker
pharma

Cancer drug pricing: Is it the worst deal for patients?

Cancer drug pricing reveals shocking disparities affecting patients.

September 22, 2026 Rose Parker
pharma

Japan approval for cenobamate: A Clear Milestone Achievement

Japan approval for cenobamate marks a significant milestone for SK biopharmaceuticals.

September 17, 2026 Rose Parker
general news

Free Child Care Program: The Rocky Start You Need to Know

Free child care program had a rocky start, revealing challenges and potential solutions.

September 8, 2026 Rose Parker
politics

PM Teacher’s Day speech sparks anger with real jibe

PM Teacher's Day speech causes outrage after 'naraz phupha' comment.

September 8, 2026 Rose Parker
Business

Nuru Massage in London Offering a Unique Sensual Journey in Full Privacy

If you’ve been searching for a truly unique way to unwind and reconnect with your senses, Nuru massage in London…

June 11, 2026 Wayne Lee
Health

How Kerala India Offers Comprehensive Weight Loss Treatments Tailored to Individual Needs

Kerala, India, is increasingly recognized for its holistic approach to health and wellness, particularly in the field of weight loss.…

October 13, 2025 Wayne Lee
Health

Blood sugar management techniques in medical weight loss

Managing blood sugar plays a vital role in successful weight loss journeys. The relationship between blood sugar levels and weight…

November 11, 2024 Wayne Lee
Dental

Innovative Dental Solutions: The Best Labs in Los Angeles

In the vast cityscape of Los Angeles, where the pursuit of perfection is often equated to the bright lights of…

March 22, 2024 Wayne Lee

Posts pagination

1 2 3 … 7

You missed

pharma

UK MHRA Approval: Is It the Best Choice for Mesalazine?

November 5, 2026 Rose Parker
pharmaceutical news

FDA Approval for Amifampridine: Is it the Best Treatment?

November 2, 2026 Rose Parker
pharmaceuticals

FDA Approval Ketamine Drug: A Proven Breakthrough

October 30, 2026 Rose Parker
pharma

Drug-price controls: The Right Approach for Patient Lives

October 27, 2026 Rose Parker
Contact Us·About Us·Disclaimer·Privacy Policy·Write for Us·Advertise with Us
Health Report World

Health Report World

Your Global Resource for Health Insights

Proudly powered by WordPress | Theme: Pulse News by Themeansar.

  • Home
  • About Us
  • Advertise with Us
  • Contact Us
  • Disclaimer
  • Editorial Policy
  • Fact-Checking & Corrections Policy
  • Sponsored Content Policy
  • Terms & Conditions
  • Write for Us